SUPN  valuation analysis

Basics
Name: Supernus Pharmaceuticals Inc
Description: Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 03, 2021
Market cap: $1.67B (1113th)
Sales(TTM): $564.28M (1180th)
Earnings(TTM): $81.75M (982nd)

Value
FFER: 1.00 (why)
Actual price: $30.73
FFEThis is Supernus Pharmaceuticals Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $30.73
Quantile: SUPN is cheap given its fundamentals.
Prices as of EOD 2021-12-22
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Supernus Pharmaceuticals Inc
"Drug Manufacturers-Specialty & Generic" industry